vs
Fidelity National Financial, Inc.（FNF）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Fidelity National Financial, Inc.的1.1倍（$622.0M vs $544.0M），Royalty Pharma plc净利率更高（34.4% vs -21.5%，领先55.9%），Fidelity National Financial, Inc.同比增速更快（10.3% vs 4.8%），过去两年Fidelity National Financial, Inc.的营收复合增速更高（13.7% vs 4.6%）
富达国民金融是美国财富500强企业，主要面向房地产与抵押贷款行业提供产权保险及交割服务，2019年其产权及房地产业务相关年度营收约为84.69亿美元，是全球领先的产权保险服务供应商。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FNF vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$544.0M
营收增速更快
FNF
高出5.6%
4.8%
净利率更高
RPRX
高出55.9%
-21.5%
两年增速更快
FNF
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $544.0M | $622.0M |
| 净利润 | $-117.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 82.9% | 62.4% |
| 净利率 | -21.5% | 34.4% |
| 营收同比 | 10.3% | 4.8% |
| 净利润同比 | -126.0% | 2.9% |
| 每股收益（稀释后） | $-0.44 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNFRPRX
| Q4 25 | $544.0M | $622.0M | ||
| Q3 25 | $553.0M | $609.3M | ||
| Q2 25 | $547.0M | $578.7M | ||
| Q1 25 | $455.0M | $568.2M | ||
| Q4 24 | $493.0M | $593.6M | ||
| Q3 24 | $506.0M | $564.7M | ||
| Q2 24 | $504.0M | $537.3M | ||
| Q1 24 | $421.0M | $568.0M |
净利润FNFRPRX
| Q4 25 | $-117.0M | $214.2M | ||
| Q3 25 | $358.0M | $288.2M | ||
| Q2 25 | $278.0M | $30.2M | ||
| Q1 25 | $83.0M | $238.3M | ||
| Q4 24 | $450.0M | $208.2M | ||
| Q3 24 | $266.0M | $544.0M | ||
| Q2 24 | $306.0M | $102.0M | ||
| Q1 24 | $248.0M | $4.8M |
营业利润率FNFRPRX
| Q4 25 | 82.9% | 62.4% | ||
| Q3 25 | 81.9% | 70.1% | ||
| Q2 25 | 69.8% | 36.3% | ||
| Q1 25 | 24.4% | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | 61.9% | — | ||
| Q2 24 | 90.9% | 50.2% | ||
| Q1 24 | 78.6% | -13.0% |
净利率FNFRPRX
| Q4 25 | -21.5% | 34.4% | ||
| Q3 25 | 64.7% | 47.3% | ||
| Q2 25 | 50.8% | 5.2% | ||
| Q1 25 | 18.2% | 41.9% | ||
| Q4 24 | 91.3% | 35.1% | ||
| Q3 24 | 52.6% | 96.3% | ||
| Q2 24 | 60.7% | 19.0% | ||
| Q1 24 | 58.9% | 0.8% |
每股收益（稀释后）FNFRPRX
| Q4 25 | $-0.44 | $0.49 | ||
| Q3 25 | $1.33 | $0.67 | ||
| Q2 25 | $1.02 | $0.07 | ||
| Q1 25 | $0.30 | $0.55 | ||
| Q4 24 | $1.65 | $0.46 | ||
| Q3 24 | $0.97 | $1.21 | ||
| Q2 24 | $1.12 | $0.23 | ||
| Q1 24 | $0.91 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.6B | $618.7M |
| 总债务越低越好 | $4.4B | $9.0B |
| 股东权益账面价值 | $7.4B | $9.7B |
| 总资产 | $109.0B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.59× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FNFRPRX
| Q4 25 | $2.6B | $618.7M | ||
| Q3 25 | $3.5B | $938.9M | ||
| Q2 25 | $3.3B | $631.9M | ||
| Q1 25 | $4.5B | $1.1B | ||
| Q4 24 | $3.5B | $929.0M | ||
| Q3 24 | $5.0B | $950.1M | ||
| Q2 24 | $4.9B | $1.8B | ||
| Q1 24 | $3.5B | $843.0M |
总债务FNFRPRX
| Q4 25 | $4.4B | $9.0B | ||
| Q3 25 | $4.4B | $8.9B | ||
| Q2 25 | $4.4B | $8.0B | ||
| Q1 25 | $4.4B | $7.6B | ||
| Q4 24 | $4.3B | $7.6B | ||
| Q3 24 | $4.2B | $7.6B | ||
| Q2 24 | $4.2B | $7.6B | ||
| Q1 24 | $3.9B | $6.1B |
股东权益FNFRPRX
| Q4 25 | $7.4B | $9.7B | ||
| Q3 25 | $8.4B | $9.6B | ||
| Q2 25 | $7.9B | $9.5B | ||
| Q1 25 | $7.9B | $9.8B | ||
| Q4 24 | $7.8B | $10.3B | ||
| Q3 24 | $8.1B | $10.3B | ||
| Q2 24 | $7.3B | $9.8B | ||
| Q1 24 | $7.1B | $9.9B |
总资产FNFRPRX
| Q4 25 | $109.0B | $19.6B | ||
| Q3 25 | $106.6B | $19.3B | ||
| Q2 25 | $102.3B | $18.3B | ||
| Q1 25 | $98.2B | $17.6B | ||
| Q4 24 | $95.4B | $18.2B | ||
| Q3 24 | $94.7B | $18.0B | ||
| Q2 24 | $88.8B | $17.7B | ||
| Q1 24 | $84.5B | $16.1B |
负债/权益比FNFRPRX
| Q4 25 | 0.59× | 0.92× | ||
| Q3 25 | 0.53× | 0.93× | ||
| Q2 25 | 0.56× | 0.84× | ||
| Q1 25 | 0.56× | 0.78× | ||
| Q4 24 | 0.56× | 0.74× | ||
| Q3 24 | 0.52× | 0.74× | ||
| Q2 24 | 0.58× | 0.78× | ||
| Q1 24 | 0.55× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.5B | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FNFRPRX
| Q4 25 | $1.5B | $827.1M | ||
| Q3 25 | $1.3B | $702.6M | ||
| Q2 25 | $1.9B | $364.0M | ||
| Q1 25 | $1.1B | $596.1M | ||
| Q4 24 | $1.5B | $742.5M | ||
| Q3 24 | $2.4B | $703.6M | ||
| Q2 24 | $1.4B | $658.2M | ||
| Q1 24 | $1.6B | $664.6M |
现金转化率FNFRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 3.66× | 2.44× | ||
| Q2 25 | 6.82× | 12.06× | ||
| Q1 25 | 13.43× | 2.50× | ||
| Q4 24 | 3.32× | 3.57× | ||
| Q3 24 | 8.89× | 1.29× | ||
| Q2 24 | 4.45× | 6.45× | ||
| Q1 24 | 6.42× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FNF
| Escrow Fees | $241.0M | 44% |
| Other Title Related Fees And Income | $182.0M | 33% |
| Service Link Excluding Title Premiums Escrow Fees And Subservicing Fees | $87.0M | 16% |
| Insurance Contracts Home Warranty | $31.0M | 6% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
